The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.

The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.

The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.

ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced today

The International Society for Stem Cell Research (ISSCR) welcomes the decision of the US Supreme Court to deny certiorari in the case of Sherley v Sebelius, which had challenged federal funding of human embryonic stem cell research.

The International Society for Stem Cell Research (ISSCR) announces the launch of Stem Cell Reports, its new online, open-access journal. With a focus on shorter, single-point articles, Stem Cell Reports will publish high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine.

The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.

The International Society for Stem Cell Research (ISSCR) welcomes the finding of the U.S. Court of Appeals for the District of Columbia upholding an earlier dismissal of Sherley v Sebelius, a court case that had challenged federal funding of human embryonic stem cell research.

The ISSCR will hold its 10th annual meeting June 13-16, 2012, in Yokohama, Japan, at the PACIFICO Yokohama.

The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.

The ISSCR is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology

The International Society for Stem Cell Research (ISSCR) welcomes today’s announcement of an advance in stem cell science and reprogramming through somatic cell nuclear transfer or SCNT.

The ISSCR applauds the decision announced today by the U.S. District Court for the District of Columbia in the case of Sherley v. Sebelius, dismissing challenges to the U.S. National Institutes of Health’s (NIH’s) funding of human embryonic stem cell research.

The ISSCR reiterates its statement of April below in support of hESC research and policies that promote the responsible development of new therapies.

Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week’s injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs).